Research for the Future
The world of ophthalmic research is an ever-changing phenomenon. Comorbid diseases and ophthalmic disorders are on the rise and present a significant burden on society, so the search for new treatments is more important and relevant than ever.
Our research department has been involved in numerous FDA-monitored, national multicenter trials. The effectiveness of Albemarle Clinical Trials is signified by our pharmaceutical and surgical company partners, to whom we provide accurate and reliable data.
Our dedicated team is committed to patient safety and improving ocular health, which is why we are always searching for new treatment options, medications, and medical devices that can benefit our patients.
Contact us today to book an appointment and get more information on our clinical trials.
Current & Past Clinical Trials
Current and past clinical trial indications include:
- Glaucoma surgery with cataract surgery
- Astigmatism correction with cataract surgery
- Diabetic retinopathy and post-operative inflammation after cataract surgery
Along with our clinical trial indications our current and past sponsors include:
- Baush & Lomb
- Reata Pharmaceuticals
- Xigen S.A.
- Eyegate Pharmaceuticals
Dr. Jitendra Swarup and his team at Albemarle Eye Center have proudly participated in phase II and phase III drug studies as well as phase IV and post-approval device studies.
Albemarle Clinical Trials
At Albemarle Eye Center, our research department continues to take part in numerous FDA-monitored clinical trials.
We’re committed to improving ocular health, which is why we’re always on the search for new treatment options, medications, and medical devices that can benefit our patients.
Check us out on Facebook
We are a proud partner of US Eye, a leading group of patient-centric, vertically integrated multi-specialty physician practices providing patients with care in ophthalmology, optometry, dermatology, audiology and cosmetic facial surgery.